Enb Therapeutics
Get Full AccessDescription
- ENB Therapeutics is developing therapies to break drug resistance that occurs in over 50% of cancer patients. Our lead product, ENB-001, is a first-in-class, selective small molecule endothelin B receptor (ETBR) inhibitor shown in multiple preclinical studies to significantly reduce tumor growth and prolong survival in cancer animal models. ENB-001 is the key to unlock the full therapeutic potential of immunotherapy by restoring the ability of T-cells to infiltrate tumors, inhibiting metastasis and prolonging patient survival. Granted Orphan Drug Designation by FDA in 2016, ENB-001 has solid market exclusivity and strong IP. A low cost, time efficient development program provides near-term POC within 18 months from financing. A companion diagnostic will detect ETBR pathway over-expressers creating additional opportunities for indication expansion into multiple tumor types and broader participation in the multi-billion-dollar immunotherapy market.
-
Headquarters:166 Fifth Avenue , New York, New York, United States
More -
Phone Number: +1 212-792-2317
-
Website: https://www.enbpharma.com
-
Employees:8
-
Revenue:$1 - 10M
-
Legal Name:Enb Therapeutics
-
Enb Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 238990 |
Show More
Frequently Asked Questions regarding Enb Therapeutics
-
Where are Enb Therapeutics's Headquarters?
Enb Therapeutics's Headquarters are in 166 Fifth Avenue ,New York,New York,United States
-
What is Enb Therapeutics's phone number?
Enb Therapeutics's phone number is +1 212-792-2317
-
What is Enb Therapeutics's official website?
Enb Therapeutics's official website is https://www.enbpharma.com
-
What is Enb Therapeutics's Revenue?
Enb Therapeutics's revenue is $1 - 10M
-
What is Enb Therapeutics's NAICS code?
Enb Therapeutics's NAICS code is 238990
-
How many employees are working in Enb Therapeutics
Enb Therapeutics has 8 employees
-
What is Enb Therapeutics's Industry?
Enb Therapeutics is in the industry of Pharmaceuticals
-
Who is Enb Therapeutics's Chief Operating Officer?
Enb Therapeutics's Chief Operating Officer is Sandy Harm

